Supernus Pharmaceuticals (NASDAQ:SUPN) Earnings Information
Supernus Pharmaceuticals last released its earnings data on February 25th, 2021. The specialty pharmaceutical company reported $0.57 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.57. The firm earned $143.56 million during the quarter, compared to analysts' expectations of $145.52 million. Supernus Pharmaceuticals has generated $2.10 earnings per share over the last year and currently has a price-to-earnings ratio of 13.2. Supernus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.
Supernus Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Supernus Pharmaceuticals (NASDAQ:SUPN) Earnings Estimates
2021 EPS Consensus Estimate: $1.28
2022 EPS Consensus Estimate: $1.99
Supernus Pharmaceuticals (NASDAQ SUPN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)